SCHOTT solutions no. 1/2013 > Pharmaceutical Systems

Photo: SCHOTT/A. Sell
New Standards in India
SCHOTT opened India’s first fully automated pharmaceutical packaging plant – a strategic move to help its customers to meet their own growth objectives.
Günther Unterholzner
The city of Jambusar is located only about an hour away from Mumbai by plane in the western Indian state of Gujarat. For years, it has played a key role in the development of India’s pharmaceutical industry. SCHOTT, for instance, has been manufacturing high-quality pharmaceutical tubing in Jambusar since 1998. This year, the company again made a strategic move and opened India’s first fully automated pharmaceutical packaging plant here.The new production facility for pharmaceutical packaging located in the immediate vicinity of its existing tubing plant expands SCHOTT Pharmaceutical Systems’ global production network to
5 tubing production sites and 17 primary packaging production sites, two of them being located in India. They are both operated by SCHOTT KAISHA, a joint venture the company entered into together with Kaisha Manufacturers Private Ltd. back in 2008. The Indo-German joint venture already operates a plant in the West Indian city of Daman and therefore knows the market extremely well.

Jambusar is not only the first fully automated production facility on the Indian subcontinent, it also meets the requirements defined in the ISO 15378 standard. Photo: SCHOTT/A. Sell
Jambusar is not only the first fully automated production facility on the Indian subcontinent, it also meets the requirements defined in the ISO15378 standard. This is a good example of the commitment to manufacturing in accordance with the international GMP (Good Manufacturing Practice) standard that serves as an important guideline for the pharmaceutical industry.
The new plant will also enable SCHOTT to extend its strategic position in the pharmaceutical market even further. Dr. Jürgen Sackhoff, Executive Vice President of the Pharmaceutical Systems Business, says manufacturing close to the market is vital to meeting the diverse needs of the customers.

Photo: SCHOTT/A. Sell
In line with the growing market, the quality requirements for pharmaceutical products and production processes also continue to rise. Consequently investments aiming at increasing high-quality packaging capacity become a logical strategic move. This view is also shared by the company’s customers. About 250 of them followed the invitation to celebrate the inauguration of this new model plant for the Indian subcontinent.

Photo: SCHOTT/A. Sell
Strong footprint in pharmerging markets
The company says the main objective behind these investments is to improve its ability to supply high-quality products to the local Indian pharma companies. ”This is really the key to helping the pharmaceutical industry benefit from high growth opportunities,” Sackhoff notes. He then emphasizes two strengths he feels are unique to SCHOTT: a true global footprint and uniform global standards for high quality. This applies to both mature markets and the so-called pharmerging markets. Pharmerging markets have one thing in common: their pharmaceutical sector is experiencing above average growth and their public health programs are expanding, along with the populations’ access to medicines.
The new plant in India will also enable SCHOTT to extend its strategic position in the pharmaceutical market even further. Photo: SCHOTT/A. Sell
Your contacts
christina.rettig@schott.com
christina.rettig@schott.com
You are here: